Skip to content

Study on effectiveness of Hydrocortisone in reducing complications of pancreatic surgery

Efficacy of peri operative hydrocortisone treatment in reducing post operative complications after pancreatic resection - A Randomised Controlled Trial - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055280
Enrollment
128
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K869- Disease of pancreas, unspecified Health Condition 2: C259- Malignant neoplasm of pancreas, unspecified

Interventions

Intervention1: HYDROCORTISONE: The intervention group receives Hydrocortisone 100 mg in 100 ml 0.9% NS every eight hours until the second postoperative day (total of 9 doses). Control Intervention1: 0

Sponsors

Dr Anantha Krishna V R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective pancreatic resection for benign / malignant lesions ( Pancreaticoduodenecomty / Distal Pancreatectomy ± Splenectomy / Median Pancreatectomy ) 2. Patients giving consent for trial

Exclusion criteria

Exclusion criteria: 1.Patients 2.Patients currently receiving systemic therapy with glucocorticoids for last 3 months 3.Patients with chronic pancreatitis 4.Patients with recent infection ( infection within 2 weeks) Cholangitis, Pneumonia, UTI

Design outcomes

Primary

MeasureTime frame
Frequency of patients with postoperative complications occurring within 90 days after surgery.Timepoint: Within 90 days of surgery

Secondary

MeasureTime frame
Development of clinically significant Post operative pancreatic fistulaTimepoint: within 90 days of surgery;Development of Delayed Gastric EmptyingTimepoint: within 90 days of surgery;Development of Post operative Pancreatic HemorrhageTimepoint: within 90 days of surgery;Length of hospital stayTimepoint: within 90 days of surgery;Ninety-day post operative mortalityTimepoint: within 90 days of surgery

Countries

India

Contacts

Public ContactAnantha krishna V R

Government Medical College, Thiruvananthapuram.

akvrkrsna@gmail.com9447376367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026